Loading...
Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
BACKGROUND: Due to the progressive nature of type 2 diabetes mellitus (T2DM), antidiabetic treatment needs to be continuously intensified to avoid long-term complications. In T2DM patients on either basal insulin-supported oral therapy (BOT) or supplementary insulin therapy (SIT) presenting with HbA...
Na minha lista:
| Udgivet i: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4642811/ https://ncbi.nlm.nih.gov/pubmed/26604774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S82720 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|